| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6780881 (Pediatric) | WYETH PHARMS | Freeze-dried pantoprazole preparation and pantoprazole injection |
May, 2022
(1 year, 4 months ago) | |
|
US7351723 (Pediatric) | WYETH PHARMS | Freeze-dried pantoprazole preparation and pantoprazole injection |
May, 2022
(1 year, 4 months ago) | |
|
US8754108 (Pediatric) | WYETH PHARMS | Freeze-dried pantoprazole preparation and pantoprazole injection |
May, 2022
(1 year, 4 months ago) | |
Protonix Iv is owned by Wyeth Pharms.
Protonix Iv contains Pantoprazole Sodium.
Protonix Iv has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Protonix Iv are:
- US6780881*PED
- US7351723*PED
- US8754108*PED
Protonix Iv was authorised for market use on 22 March, 2001.
Protonix Iv is available in injectable;intravenous dosage forms.
The generics of Protonix Iv are possible to be released after 17 May, 2022.
Drugs and Companies using PANTOPRAZOLE SODIUM ingredient
Market Authorisation Date: 22 March, 2001
Treatment: NA
Dosage: INJECTABLE;INTRAVENOUS
PROTONIX IV family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic